GLC

alpha-D-glucopyranose

Created:	1999-07-08
Last modified:	2024-09-27

Find Related PDB Entry
322 entries where GLC is found as a standalone ligand69 entries where GLC is covalently linked to polymer or other heterogen groups 1,777 entries where GLC is found in a branched oligosaccharide

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	24
Chiral Atom Count	5
Bond Count	24
Aromatic Bond Count	0

2D diagram of GLC

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	alpha-D-glucopyranose
Synonyms	alpha-D-glucose; D-glucose; glucose
Systematic Name (OpenEye OEToolkits)	(2S,3R,4S,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol
Formula	C₆ H₁₂ O₆
Molecular Weight	180.156
Type	D-SACCHARIDE, ALPHA LINKING

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	OC1C(O)C(OC(O)C1O)CO
SMILES	CACTVS	3.341	OC[CH]1O[CH](O)[CH](O)[CH](O)[CH]1O
SMILES	OpenEye OEToolkits	1.5.0	C(C1C(C(C(C(O1)O)O)O)O)O
Canonical SMILES	CACTVS	3.341	OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O
Canonical SMILES	OpenEye OEToolkits	1.5.0	C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O)O)O)O)O
InChI	InChI	1.03	InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6+/m1/s1
InChIKey	InChI	1.03	WQZGKKKJIJFFOK-DVKNGEFBSA-N

Related Resource References

Resource Name	Reference
PubChem	79025
ChEMBL	CHEMBL423707
ChEBI	CHEBI:17925, CHEBI:28100, CHEBI:15444, CHEBI:18398, CHEBI:28102, CHEBI:18269
CCDC/CSD	GLUCMH11, GLUCMH12, FOWVIY, GLUCSA03, GLUCSA15, GLUCSA11, GLUCSA10, GLUCSA16, GLUCSA19, GLUCSA17, GLUCSA, GLUCSA14, GLUCSA18, GLUCSA13, GLUCSA12, GLUCSA20
COD	1558408, 1518440, 1518437, 1518433, 1518446, 1518445, 1518438, 1518439, 1518443, 1518441, 1518436, 1518442, 1518435, 1518434, 1518432, 1518444

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.